| Primary |
| Acute Myocardial Infarction |
23.8% |
| Stent Placement |
19.6% |
| Acute Coronary Syndrome |
16.8% |
| Percutaneous Coronary Intervention |
6.5% |
| Angina Pectoris |
5.6% |
| Myocardial Infarction |
5.6% |
| Myocardial Ischaemia |
5.1% |
| Thrombosis Prophylaxis |
2.3% |
| Coronary Artery Disease |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Angiogram |
1.4% |
| Essential Hypertension |
1.4% |
| Tuberculosis |
1.4% |
| Angioplasty |
0.9% |
| Anticoagulant Therapy |
0.9% |
| Cardiac Failure Congestive |
0.9% |
| Chest Pain |
0.9% |
| Congestive Cardiomyopathy |
0.9% |
| Coronary Angioplasty |
0.9% |
| Haemodynamic Instability |
0.9% |
|
| Coronary Artery Restenosis |
23.7% |
| Thrombosis In Device |
17.1% |
| Angina Pectoris |
5.3% |
| Gastrointestinal Haemorrhage |
5.3% |
| Device Occlusion |
3.9% |
| Sudden Death |
3.9% |
| Thrombocytopenia |
3.9% |
| Transient Ischaemic Attack |
3.9% |
| Ventricular Fibrillation |
3.9% |
| Angina Unstable |
2.6% |
| Cardiogenic Shock |
2.6% |
| Haemoglobin Decreased |
2.6% |
| Hypertensive Crisis |
2.6% |
| Multi-organ Failure |
2.6% |
| Myocardial Infarction |
2.6% |
| Off Label Use |
2.6% |
| Rectal Haemorrhage |
2.6% |
| Shock Haemorrhagic |
2.6% |
| Syncope |
2.6% |
| Tachycardia |
2.6% |
|
| Secondary |
| Acute Myocardial Infarction |
21.0% |
| Stent Placement |
19.9% |
| Acute Coronary Syndrome |
16.1% |
| Angina Pectoris |
7.5% |
| Percutaneous Coronary Intervention |
4.8% |
| Coronary Angioplasty |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Coronary Artery Disease |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Myocardial Ischaemia |
3.2% |
| Arteriogram Coronary |
1.6% |
| Tuberculosis |
1.6% |
| Cardiac Failure Congestive |
1.1% |
| Congestive Cardiomyopathy |
1.1% |
| Essential Hypertension |
1.1% |
| Hiv Infection |
1.1% |
| Myocardial Infarction |
1.1% |
| Peripheral Arterial Occlusive Disease |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Anticoagulant Therapy |
0.5% |
|
| Coronary Artery Restenosis |
28.8% |
| Thrombosis In Device |
12.1% |
| Angina Pectoris |
6.1% |
| Acute Generalised Exanthematous Pustulosis |
4.5% |
| Coronary Artery Thrombosis |
4.5% |
| Drug Ineffective |
4.5% |
| Syncope |
4.5% |
| Thrombocytopenia |
4.5% |
| Device Occlusion |
3.0% |
| Gastrointestinal Haemorrhage |
3.0% |
| Multi-organ Failure |
3.0% |
| Off Label Use |
3.0% |
| Ventricular Fibrillation |
3.0% |
| Vomiting |
3.0% |
| Weight Decreased |
3.0% |
| Wound Haemorrhage |
3.0% |
| Acute Coronary Syndrome |
1.5% |
| Acute Myocardial Infarction |
1.5% |
| Angina Unstable |
1.5% |
| Cardiac Tamponade |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.6% |
| Hypertension |
14.8% |
| Acute Coronary Syndrome |
6.1% |
| Dyslipidaemia |
6.1% |
| Infarction |
5.2% |
| Type 2 Diabetes Mellitus |
4.3% |
| Essential Thrombocythaemia |
3.5% |
| Hiv Infection |
3.5% |
| Coronary Artery Disease |
2.6% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Anticoagulant Therapy |
0.9% |
| Arterial Thrombosis |
0.9% |
| Blood Cholesterol Abnormal |
0.9% |
| Blood Cholesterol Increased |
0.9% |
| Blood Triglycerides Increased |
0.9% |
| Cardiac Failure |
0.9% |
| Cardiovascular Event Prophylaxis |
0.9% |
| Chronic Myeloid Leukaemia |
0.9% |
| Complications Of Transplanted Kidney |
0.9% |
|
| Shock |
19.2% |
| Myalgia |
7.7% |
| Oesophagitis |
7.7% |
| Thrombosis In Device |
7.7% |
| Dyspnoea |
3.8% |
| Hyperlipasaemia |
3.8% |
| Insomnia |
3.8% |
| Myocardial Infarction |
3.8% |
| Obstruction |
3.8% |
| Oedema Peripheral |
3.8% |
| Pain In Extremity |
3.8% |
| Pancreatitis |
3.8% |
| Peripheral Sensory Neuropathy |
3.8% |
| Pruritus |
3.8% |
| Renal Failure Acute |
3.8% |
| Rotator Cuff Syndrome |
3.8% |
| Thrombocytopenia |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Wound Infection |
3.8% |
|
| Interacting |
| Myocardial Ischaemia |
33.3% |
| Coronary Artery Disease |
16.7% |
| Hypertension |
16.7% |
| Pain |
16.7% |
| Petit Mal Epilepsy |
16.7% |
|
| Feeling Abnormal |
50.0% |
| Melaena |
50.0% |
|
